Health Professional Radio - Podcast

Dr. Tim Rodell, M.D., CEO and Director at Aethlon Medical, Inc., discusses the Hemopurifier®, a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The Hemopurifier has existing Investigational Device Exemption in cancer and life-threatening viral infections and the FDA has recently supplemented to its IDE in viral disease to include SARS-CoV-2/COVID-19. In 2014, a Ugandan pediatrician who had been treating Ebola patients became infected himself. The Hemopurifier was used to extract the virus from the pediatrician’s blood and ultimately saved his life.